NASDAQ:ODTX

Odyssey Therapeutics Q1 2026 Earnings Results & Report

$19.36 +0.22 (+1.15%)
As of 04:00 PM Eastern

Odyssey Therapeutics missed analyst earnings expectations in its Q1 2026 results, released June 17, 2026. The company reported EPS of -$6.77 versus the -$1.31 consensus estimate.

Earnings Announcement Details

Quarter
Q1 2026
Report Date
Time
After Market Closes
Conference Call
8:00 AM ET

Odyssey Therapeutics EPS Results

Actual EPS
-$6.77
Consensus EPS
-$1.31
Beat/Miss
Missed by -$5.46
One Year Ago EPS
N/A

Odyssey Therapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Odyssey Therapeutics Q1 2026 Earnings FAQ

Odyssey Therapeutics (NASDAQ:ODTX) reported earnings of -$6.77 per share for Q1 2026, missing the consensus estimate of -$1.31. The report was announced on Wednesday, June 17, 2026.

Odyssey Therapeutics Earnings Headlines

What is HC Wainwright's Estimate for ODTX FY2026 Earnings?
Every Starlink dish pays this stock
There's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now he's filed to launch 1,000,000 AI satellites, a move Dylan believes could mean a 100X bigger royalty bill starting December 8th. This free pick names the public company collecting on every unit.tc pixel
What is HC Wainwright's Forecast for ODTX Q1 Earnings?
See More Odyssey Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Odyssey Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Odyssey Therapeutics and other key companies, straight to your email.

About Odyssey Therapeutics

Odyssey Therapeutics (NASDAQ:ODTX) is a biotechnology company focused on discovering and developing medicines for inflammatory and autoimmune diseases. Its research centers on the immune system and biological pathways that may be targeted to address these conditions.

Founded in 2021, the company uses drug-discovery capabilities to identify and advance potential therapies. Its business is research and development rather than the sale of marketed medicines.

Odyssey is based in the United States. As a research-focused biotechnology company, its activities are centered on developing potential treatments rather than serving patients through a broad commercial product operation.

View Odyssey Therapeutics Profile